Lead a global team to deliver integrated, high-quality evidence aligned with therapeutic and business objectives
Oversee design and execution of Phase IIIb/IV trials, non-interventional studies, and Real World Evidence programs
Align evidence generation strategies with medical and access priorities across global functions and key countries
Drive innovation using novel methodologies, digital technologies, and real-world data sources
Influence therapeutic area strategy as part of the TA Medical Leadership Team
Champion operational excellence and talent development within the Evidence Generation Leadership Team
Build strategic partnerships internally and externally to enhance collaboration and scientific impact
Requirements
Advanced degree (MD, PhD, PharmD, or equivalent) in life sciences, public health, or a related field
Extensive experience in evidence generation within pharma, academia, or healthcare settings
Proven expertise in designing and executing interventional, non-interventional, and Real World Evidence studies
Strong leadership and collaboration skills in global, cross-functional environments
Ability to translate scientific insights into strategic decisions that drive product and stakeholder impact
Excellent communication skills with the ability to engage diverse internal and external audiences
Skills Desired: Clinical Practices, Clinical Research, Drug Development, E-Learning, Influencing Skills, Leadership, Medical Communication, Microsoft Access, Patient Care, Pharmaceutics, Pipeline (Software), Product Placement, Regulatory Compliance, Software Release, Strategic Direction, Well-Being
Benefits
Hybrid Working, LI-Hybrid
You can find everything you need to know about our benefits and rewards in the Novartis Life Handbook.
Commitment to Diversity and Inclusion
Join our Novartis Network
Applicant Tracking System Keywords
Tip: use these terms in your resume and cover letter to boost ATS matches.
Hard skills
evidence generationPhase IIIb trialsPhase IV trialsnon-interventional studiesReal World Evidenceclinical researchdrug developmentclinical practicesregulatory compliancemedical communication